pI: 9.9387 |
Length (AA): 242 |
MW (Da): 27468 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_129325)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G30970 | protein SUPPRESSOR of FRI 4 |
Babesia bovis | BBOV_IV002940 | zinc finger protein 207 |
Brugia malayi | Bm1_08820 | Zinc finger protein 207 |
Caenorhabditis elegans | CELE_B0035.1 | Protein B0035.1, isoform A |
Cryptosporidium hominis | Chro.10037 | hypothetical protein |
Cryptosporidium parvum | cgd1_270 | zinc finger protein |
Dictyostelium discoideum | DDB_G0290105 | C2H2-type zinc finger-containing protein |
Drosophila melanogaster | Dmel_CG17912 | CG17912 gene product from transcript CG17912-RF |
Echinococcus granulosus | EgrG_000688100 | zinc finger C2H2 type |
Echinococcus multilocularis | EmuJ_000688100 | zinc finger, C2H2 type |
Homo sapiens | ENSG00000010244 | zinc finger protein 207 |
Loa Loa (eye worm) | LOAG_08264 | zinc finger protein |
Mus musculus | ENSMUSG00000017421 | zinc finger protein 207 |
Neospora caninum | NCLIV_013950 | hypothetical protein |
Oryza sativa | 4347855 | Os09g0560900 |
Plasmodium berghei | PBANKA_1207700 | zinc finger protein, putative |
Plasmodium falciparum | PF3D7_1009400 | zinc finger protein, putative |
Plasmodium knowlesi | PKNH_0809100 | zinc finger protein, putative |
Plasmodium vivax | PVX_094685 | zinc finger protein, putative |
Plasmodium yoelii | PY02536 | 49 kDa zinc finger protein |
Schistosoma japonicum | Sjp_0107350 | Zinc finger protein 207, putative |
Schistosoma mansoni | Smp_025560 | hypothetical protein |
Schmidtea mediterranea | mk4.000092.19 | ZNF207-1 |
Toxoplasma gondii | TGME49_286710 | zinc finger, c2h2 type domain-containing protein |
Theileria parva | TP01_0632 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_416930 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_119110 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
PBANKA_1207700 | Plasmodium berghei | Dispensable | plasmo |
TGME49_286710 | Toxoplasma gondii | Essentiality uncertain | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.